Takuya Araki

Clinicopathological features of lung adenocarcinoma with <i>KRAS</i> mutations

Seiichi Kakegawa, Kimihiro Shimizu, Masayuki Sugano et al. · Cancer · 2011 · 61 citations · Full text

Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

Takuya Araki, Hideaki Yashima, Kimihiro Shimizu et al. · Clinical Medicine Insights Oncology · 2012 · 50 citations · Full text

Tyrosine Kinase Inhibitor, Oncology, Pharmacology +12

Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded Lung Cancer Tissue

Yohei Miyamae, Kimihiro Shimizu, Yasumasa Mitani et al. · Journal of Molecular Diagnostics · 2010 · 46 citations · Full text

Engineering, Somatic Variant, Medicine +10

Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients

Kyoko Obayashi, Takuya Araki, Katsunori Nakamura et al. · Drugs in R&D · 2013 · 37 citations · Full text

Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon12 Mutations in Lung Adenocarcinoma

Takuya Araki, Kimihiro Shimizu, Katsunori Nakamura et al. · Journal of Molecular Diagnostics · 2009 · 36 citations · Full text

Nucleic Acid Biomarkers, Medicine, Lung Adenocarcinoma +12